Virpax Pharmaceuticals
Pharmaceutical Company
Based in PA
AI Overview
With $0 in lobbying spend across 28 quarterly filings, Virpax Pharmaceuticals is an active lobbying client. Their lobbying covers 2 issue areas. Active from 2019 to 2025.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2019 | $0 |
| 2020 | $0 |
| 2021 | $0 |
| 2022 | $0 |
| 2023 | $0 |
| 2024 | $0 |
| 2025 | $0 |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Virpax Pharmaceuticals disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Budget/Appropriations
Issues related to non-opioid pain management.
Issues related to the opioid crisis.
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.